Vaccines, Blood & Biologics
?
-
General Biologics Research
-
Biostatistics & Epidemiology
Risk Assessment Research: Development of Tools that Evaluate and Enhance the Safety of Biologic Products
Steve Anderson, PhDEvaluation of Bioinformatics Tools for the Analysis of Pharmacogenomic and Proteomic Data from Regulatory Clinical and Non-clinical Studies
Jawahar TiwariStatistical and Bioinformatics Tools for the Analysis of Blood Products and Pharmacogenomic and Proteomic Data
Boris Zaslavsky, PhDPost-marketing Monitoring of Vaccine Safety
Robert Ball, MDEvaluating the Safety of Influenza and Pneumococcal Vaccines Received by the Medicare Population
Dale R. Burwen, MSStudy of Swelling and Other Reactions to Evaluate Safety of Diptheria-Tetanus-Acellular Pertussis Vaccine
Emily Jane Woo
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-